EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in uterine inflammatory myofibroblastic tumours: Diagnostic challenges and risk stratification

Sarah E Umetsu iD, Nicholas R Ladwig iD

Histopathology · 2024-08 · 85 (2) · 215-223

DOI: 10.1111/his.15194 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Histopathology, online erschienen am 17.04.2024. Verfasst von Sarah E Umetsu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Uterine Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current understanding of inflammatory myofibroblastic tumours (IMTs) of the gynaecological tract has recently been enhanced by their increased recognition. This increase is largely due to greater accessibility to RNA‐based molecular assays used to identify their defining ALK rearrangements. This review summarises the clinical characteristics, morphological spectrum, immunohistochemical profile and molecular underpinnings of uterine IMT. Additionally, this review discusses practical diagnostic considerations including overlap between uterine IMT and smooth muscle tumours as well as pregnancy‐associated uterine IMT. Finally, we highlight recent literature demonstrating the potential for aggressive behaviour in uterine IMT, including a novel risk stratification model for identifying high‐risk IMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine NeoplasmsHumansFemaleNeoplasms, Muscle TissuePregnancyRisk AssessmentMyofibroblasts

Stichwörter der Autor:innen

ALKIMTinflammatory myofibroblastic tumorrisk stratificationuterus

Autor:innen und Institutionen

  • Department of Pathology, University of California San Francisco, San Francisco, CA, USA.

ORCID-Profile: Sarah E Umetsu, Nicholas R Ladwig

Zitieren

APA

Umetsu, S. E., & Ladwig, N. R. (2024). Advances in uterine inflammatory myofibroblastic tumours: Diagnostic challenges and risk stratification. Histopathology, 85(2), 215-223. https://doi.org/10.1111/his.15194

Vancouver

Umetsu SE, Ladwig NR. Advances in uterine inflammatory myofibroblastic tumours: Diagnostic challenges and risk stratification. Histopathology. 2024;85(2):215-223. doi:10.1111/his.15194

BibTeX
@article{Umetsu2024,
  author = {Umetsu, Sarah E and Ladwig, Nicholas R},
  title = {Advances in uterine inflammatory myofibroblastic tumours: Diagnostic challenges and risk stratification},
  journal = {Histopathology},
  year = {2024},
  volume = {85},
  number = {2},
  pages = {215--223},
  doi = {10.1111/his.15194}
}
Kostenlos starten →